Electronic Nose Technology for Early Detection of Ovarian Cancer
Electronic nose technology may detect early signs of ovarian cancer through blood analysis. Promising advancements in cancer diagnosis. π©Ίπ¬
April 20, 2026
Follow us
latest articles
Discover the newest research about AI innovations in π Oncology.
Concerns Over AI Cancer Tools Relying on Statistical Shortcuts
AI cancer tools may depend on shortcuts, raising concerns about their reliability in diagnosing cancer accurately. π§¬π
April 18, 2026
Artificial intelligence in cancer survivorship: evaluating ChatGPT’s performance in rehabilitation-related queries.
AI in Cancer Rehab: ChatGPT’s Accuracy at 3.93/5 π, Completeness 2.13/3 π, Global Quality 3.60/5 π.
April 18, 2026
Multi-omics applications in health and diseases.
Multi-omics integration enhances precision medicine, addressing disease complexity with AI-driven analysis. Key for future healthcare advancements! ππ¬
April 16, 2026
Personalized Neoantigen Cancer Vaccines: Why Clinical Benefit Remains Inconsistent.
Personalized cancer vaccines show promise but face challenges like predictive accuracy and tumor evolution. Key insights from recent research. ππ
April 14, 2026
Smart hydrogels for overcoming cancer multidrug resistance.
Smart hydrogels target cancer multidrug resistance by remodeling tumor ecosystems, enhancing drug delivery, and boosting antitumor immunity. ππ§¬
April 12, 2026
PRET is a few-shot system for pan-cancer recognition without example training.
Revolutionary AI in Cancer Diagnosis: PRET Achieves 97% Accuracy with Minimal Data! π§¬π
April 5, 2026
SGA-DT: An adaptive fusion framework for missing data imputation and interpretable healthcare classification.
SGA-DT framework enhances healthcare predictions by addressing missing data with adaptive strategies. ππ€ Robust, interpretable, and accurate!
March 27, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.
AI in CLL Research: 586 Patients Analyzed, 29.7% Started Treatment, 42.8% TP53 Aberrations. ππ
March 19, 2026
AI Tool Predicts Heart Attack Risks in Cancer Patients
AI tool assesses heart attack risks in cancer patients, aiding in better health management. π«π€
March 14, 2026